SEC Filing Details

Document Details

Filing Date
Aug 9, 2022
Document Date
Aug 9, 2022
Form Description
Amendment to a previously filed SC 14D9
Filing Group
Mergers & Acquisitions
Company
Turning Point Therapeutics, Inc.
Issuer
Turning Point Therapeutics, Inc.

Turning Point Therapeutics is now a
Bristol Myers Squibb company

Select OK for information about Turning Point Therapeutics.

Select BMS to learn more about Bristol Myers Squibb